SHR-1701 not checked

Hengrui

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1/2 trial completes
Trials
3 active
18 in total
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“Phase Ⅰb/Phase Ⅱ: SHR-1701: injection, intravenous infusion Almonertinib: tablets, oral”In the company’s words, NCT05503888 on ClinicalTrials.gov
Tested for
Gastric or Gastroesophageal Junction Cancer, Advanced Gastric Cancer, Metastatic Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Relapsed or Advanced Non-small Cell Lung Cancer
Main trialPhase 3
“This study is a randomized, Double-Blind, multi-center Phase III clinical study, aimed to evaluate the efficacy and safety of SHR1701 combined with chemotherapy in the treatment of Previously Untreated, Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer. For Part 1 study,the tolerability of SHR-1701 will be evaluated and determine the recommended dose for Part 2.For Part 2 study, all enrolled patients will be randomized to 2 groups and continuously treated until the end criteria of treatment was met.”In the company’s words, NCT04950322 on ClinicalTrials.gov
Other names
Gemcitabine and Albumin Paclitaxel

Other drugs for Advanced Gastric Cancer

All 208 drugs for Advanced Gastric Cancer

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials18

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting 20 May 2024 A Trial of SHR1701 Plus Chemotherapy in Patients With Gastric or Gastroesophageal Cancer
Phase 2Recruiting Dec 2027 Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma
Phase 1/2Not yet recruiting 30 Jul 2027 Phase Ib/II Study of Almonertinib Combined With SHR-1701 in the Treatment of Relapsed or Advanced Non-small Cell Lung Cancer
Phase 3Terminated 12 Aug 2024 A Study of SHR-1701 Plus Platinum-containing Chemotherapy With or Without BP102 (Bevacizumab) as First-line Treatment in Cervical Cancer
Phase 3Unknown 30 Dec 2024 A Study of SHR-1701 Plus Bevacizumab and Chemotherapy in Non-Small-Cell-Lung-Cancer
Phase 2/3Terminated 3 Apr 2024 Clinical Study of SHR-1701 Plus Chemotherapy as Perioperative Treatment in Subjects With Gastric Cancer
Phase 2/3Terminated 17 Apr 2024 A Clinical Studyf of SHR-1701 or Placebo in Combination With BP102 and XELOX in the First-line Treatment of mCRC
Phase 2Withdrawn 15 Nov 2021 A Trial of SHR-1701 With or Without Famitinib in Patients With Advanced or Metastatic NSCLC
Phase 2Unknown 31 Dec 2022 A Trial of SHR-1701 in Combination With and Without Famitinib Malate in Patients With Extensive Stage Small Cell Lung Cancer
Phase 2Unknown Jan 2023 SHR-1701 in Patients With Recurrent/Metastatic Scchn
Phase 2Unknown 15 Jul 2023 A Trial of SHR-1701 With or Without Chemotherapy in Patients With Stage III NSCLC
Phase 1/2Completed 16 Sep 2021 A Trial of SHR-1701 in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Pancreatic Cancer
Phase 1/2Unknown May 2022 SHR-1701 in Combination With Famitinib in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma
Phase 1/2Unknown 1 Dec 2022 A Trial of SHR-1701 in Combination With Famitinib in Patients With Advanced Solid Tumors
Phase 1Unknown 16 Apr 2022 SHR-1701 in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma
Phase 1Unknown 31 Dec 2022 SHR-1701 in Metastatic or Locally Advanced Solid Tumors
Phase 1Completed 1 Feb 2023 A Trial of SHR-1701 in Subjects With Advanced Solid Tumors
Phase 1Unknown Mar 2023 SHR-1701 in Subjects With Metastatic or Locally Advanced Solid Tumors
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow SHR-1701

Following is part of Solo: you see every change to SHR-1701 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in